- BiomX Hosting Key Opinion Leader Symposium on Novel Phage Product for Acne Prone Skin
- BiomX Announces In-house Phage Manufacturing Facility
- Chardan Healthcare Acquisition Corp. Announces Merger Agreement with BiomX Ltd.
- BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program from JSR Corporation in Japan
- The tumor microbiome emerges as a new source of translational opportunities